NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/31/2022
Back to search
Official data from USPTO
ROIVANT FOUNDATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ROIVANT FOUNDATION
ST13
US500000090452438Class
5, 36, 42, 44
Filing
90452438
Registration
6742376
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/31/2022
Trademark type
Word
Nice classes
5, 36, 42, 44
Filing date
01/07/2021
Registration date
05/31/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2022
Last transaction
05/31/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
27
Owner location
Basel, CH
Examiner
AGREDA, SAMANTHA
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Roivant Sciences GmbH
Representatives
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 36Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment of central nervous systemneurologicaldementiadermatologicalmetabolichematologicinfectiousauto-immuneimmune deficiencygenetichepatologicalcardiometabolicurologicaloncologicalendocrine and endocrine-relatedgynecologicalophthalmologicalrespiratorycardiacpulmonary disordersdiseases and conditions; biologic preparations for medical and therapeutic purposes for the treatment of central nervous systemneurologicaldementiadermatologicalmetabolichematologicinfectiousauto-immuneimmune deficiencygenetichepatologicalcardiometabolicurologicaloncologicalendocrine and endocrine-relatedgynecologicalophthalmologicalrespiratorycardiacpulmonary disordersdiseases and conditions
Class 36
Charitable fundraising services
Class 42
Scientific and technological services and research and design relating theretomedical researchscientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceuticalbiomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparationsclinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticalsbiomedicineclinical trials and post-market trials
Class 44
Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2022
PUBO
PUBLISHED FOR OPPOSITION
03/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
02/10/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/10/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
02/10/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2022
DOCK
ASSIGNED TO EXAMINER
09/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2021
GNRT
NON-FINAL ACTION E-MAILED
07/17/2021
CNRT
NON-FINAL ACTION WRITTEN
07/17/2021
DOCK
ASSIGNED TO EXAMINER
07/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2021
NWAP
NEW APPLICATION ENTERED
01/11/2021
Continuous trademark protection
Get notified about every new filing that threatens ROIVANT FOUNDATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.